ArticleDiagnostics (Basel, Switzerland)2022
COVID-19 Diagnosis on Chest Radiographs with Enhanced Deep Neural Networks.
Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Automated classification of chest X-rays: a deep learning approach with attention mechanisms.BMC medical imaging · 2025Article
- Analysis of Chest X-ray for COVID-19 Diagnosis as a Use Case for an HPC-Enabled Data Analysis and Machine Learning Platform for Medical Diagnosis Support.Diagnostics (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The COVID-19 pandemic has caused a devastating impact on the social activity, economy and politics worldwide. Techniques to diagnose COVID-19 cases by examining anomalies in chest X-ray images are urgently needed. Inspired by the success of deep learning in various tasks, this paper evaluates the performance of four deep neural networks in detecting COVID-19 patients from their chest radiographs. The deep neural networks studied include VGG16, MobileNet, ResNet50 and DenseNet201. Preliminary experiments show that all deep neural networks perform promisingly, while DenseNet201 outshines other models. Nevertheless, the sensitivity rates of the models are below expectations, which can be attributed to several factors: limited publicly available COVID-19 images, imbalanced sample size for the COVID-19 class and non-COVID-19 class, overfitting or underfitting of the deep neural networks and that the feature extraction of pre-trained models does not adapt well to the COVID-19 detection task. To address these factors, several enhancements are proposed, including data augmentation, adjusted class weights, early stopping and fine-tuning, to improve the performance. Empirical results on DenseNet201 with these enhancements demonstrate outstanding performance with an accuracy of 0.999%, precision of 0.9899%, sensitivity of 0.98%, specificity of 0.9997% and F1-score of 0.9849% on the COVID-Xray-5k dataset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.